Search results
BMO raises Scholar Rock shares target on SAPPHIRE trial optimism By Investing.com
Investing.com· 2 days agoOn Thursday, BMO Capital Markets adjusted its outlook on Scholar Rock (NASDAQ:SRRK) shares,...
Lixte Biotechnology inks deal for cancer drug trial By Investing.com
Investing.com· 17 hours agoLixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) has entered into a significant agreement with the...
Syndax reports encouraging results from AML treatment trials By Investing.com
Investing.com· 18 hours agoSyndax Pharmaceuticals (NASDAQ: NASDAQ:SNDX), a clinical stage biopharmaceutical company, has...
JPMorgan's Top Strategist Sticks To Bearish S&P 500 Forecast, Warns Of 2008-Like Crash: 'Equities...
Benzinga via AOL· 4 days agoJPMorgan Chase & Co. continues to hold one of the most pessimistic views on Wall Street regarding...
Better Cybersecurity Stock: Palo Alto Networks vs. Fortinet
Motley Fool via Yahoo Finance· 4 days agoFortinet's growth is more balanced across its secure ops, secure access service edge (SASE), and...
ProKidney director Pablo Legorreta buys $54.7 million in shares By Investing.com
Investing.com· 12 hours agoIn a notable transaction, Pablo Legorreta, a director and significant shareholder of ProKidney Corp....
The 8 Most Supportive (and Comfortable) Sports Bras for Bigger Cup Sizes
Runner's World via Yahoo News· 4 days agoFit your sports bra by moving your breasts so they are sitting squarely in the cups and aren’t...
Oppenheimer cuts Spruce Biosciences shares target, cites updated revenue forecasts By Investing.com
Investing.com· 2 days agoOn Thursday, Oppenheimer adjusted its price target for Spruce Biosciences, Inc. (NASDAQ:SPRB)...
Processa reports positive Phase 1b trial results for cancer drug By Investing.com
Investing.com· 4 days agoProcessa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage pharmaceutical company, has announced...
Kiora Pharmaceuticals exec buys $7.6k in company stock By Investing.com
Investing.com· 12 hours agoIn a recent move that has caught the attention of investors, Eric Joseph Daniels, the Chief...